SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-20-002389
Filing Date
2020-05-14
Accepted
2020-05-14 16:06:41
Documents
73
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 405865
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 4797
3 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 4737
4 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 3092
5 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 3155
  Complete submission text file 0001062993-20-002389.txt   3237582

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION INSTANCE DOCUMENT igxt-20200331.xml EX-101.INS 499374
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT igxt-20200331.xsd EX-101.SCH 58367
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT igxt-20200331_cal.xml EX-101.CAL 29648
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT igxt-20200331_def.xml EX-101.DEF 120642
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT igxt-20200331_lab.xml EX-101.LAB 495999
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT igxt-20200331_pre.xml EX-101.PRE 248644
Mailing Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2
Business Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2 514-331-7440
IntelGenx Technologies Corp. (Filer) CIK: 0001098880 (see all company filings)

IRS No.: 870638336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31187 | Film No.: 20877757
SIC: 2834 Pharmaceutical Preparations